Zentalis Pharmaceuticals Is A Clinical Stage Biopharmaceutical Company Based In New Yorkwith Operations In San Diegothe Company Is Dedicated To Discovering And Developing Small Molecule Therapeutics For Oncologyaiming To Meet Unmet Needs In Cancer Treatment Through Innovative Research And Targeted Therapieszentalis Utilizes Its Integrated Discovery Enginea Proprietary Platform That Combines Expertise In Cancer Biology And Medicinal Chemistryto Identify And Advance Novel Drug Candidates The Company S Clinical Stage Pipeline Includes Several Candidatessuch As Azenosertiba Wee1 Inhibitor For Advanced Solid Tumorsand Zn C5An Oral Selective Estrogen Receptor Degrader Targeting Breast Cancerother Candidates Include Zn D5A Bcl 2 Inhibitor For Hematologic Malignanciesand Zn E4An Egfr Inhibitor For Non Small Cell Lung Carcinomazentalis Also Collaborates With Industry Leaders Like Pfizertempusand Tavros Therapeutics To Enhance Its Discovery Capabilities And Explore Combination Therapiesunder The Leadership Of Ceo Julie Eastlandzentalis Aims To Become A Leading Oncology Focused Biopharmaceutical Company By Developing New Chemical Entities With Superior Clinical Profiles
No conferences found for this company.
| Company Name | Zentalis Pharmaceuticals |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
